Nobre L, Alves Junior S, Puglia E, Rodrigues R, Zanetti G, Marchiori E
Radiol Bras. 2024; 57:e20240054.
PMID: 39635567
PMC: 11616031.
DOI: 10.1590/0100-3984.2024.0054-en.
Stegner D, Gob V, Krenzlin V, Beck S, Hemmen K, Schuhmann M
Nat Cardiovasc Res. 2024; 1(2):132-141.
PMID: 39195988
PMC: 11358028.
DOI: 10.1038/s44161-021-00017-1.
Smith C, Campos J, Brown H, Jooss N, Ivanova V, Harbi M
Blood Adv. 2024; 8(21):5557-5570.
PMID: 38968150
PMC: 11539360.
DOI: 10.1182/bloodadvances.2024012713.
Clark J, Martin E, Moran L, Di Y, Wang X, Zuidscherwoude M
Commun Biol. 2023; 6(1):376.
PMID: 37029319
PMC: 10082178.
DOI: 10.1038/s42003-023-04766-6.
Akbulut A, Arisz R, Baaten C, Baidildinova G, Barakzie A, Bauersachs R
Thromb Haemost. 2023; 123(8):808-839.
PMID: 36913975
PMC: 10365887.
DOI: 10.1055/a-2052-9175.
The Btk inhibitor AB-95-LH34 potently inhibits atherosclerotic plaque-induced thrombus formation and platelet procoagulant activity.
Smith C, Harbi M, Garcia-Quintanilla L, Rookes K, Brown H, Poulter N
J Thromb Haemost. 2022; 20(12):2939-2952.
PMID: 36239466
PMC: 9827830.
DOI: 10.1111/jth.15899.
Platelets and tyrosine kinase inhibitors: clinical features, mechanisms of action, and effects on physiology.
Zheng T, Parra-Izquierdo I, Reitsma S, Heinrich M, Larson M, Shatzel J
Am J Physiol Cell Physiol. 2022; 323(4):C1231-C1250.
PMID: 35938677
PMC: 9576167.
DOI: 10.1152/ajpcell.00040.2022.
Antithrombotic Effects of Fostamatinib in Combination with Conventional Antiplatelet Drugs.
Harbi M, Smith C, Alenazy F, Nicolson P, Tiwari A, Watson S
Int J Mol Sci. 2022; 23(13).
PMID: 35805988
PMC: 9266367.
DOI: 10.3390/ijms23136982.
Inhibition of Bruton's Tyrosine Kinase Activity Attenuates Hemorrhagic Shock-Induced Multiple Organ Dysfunction in Rats.
Patel N, Oliveira F, Pillmann Ramos H, Aimaretti E, Alves G, Coldewey S
Ann Surg. 2022; 277(3):e624-e633.
PMID: 35129479
PMC: 9891276.
DOI: 10.1097/SLA.0000000000005357.
What Function Do Platelets Play in Inflammation and Bacterial and Viral Infections?.
Tokarz-Deptula B, Palma J, Baraniecki L, Stosik M, Kolacz R, Deptula W
Front Immunol. 2021; 12:770436.
PMID: 34970260
PMC: 8713818.
DOI: 10.3389/fimmu.2021.770436.
The Possible Role of Bruton Tyrosine Kinase Inhibitors in the Treatment of COVID-19: A Review.
Rezaei M, Barati S, Babamahmoodi A, Dastan F, Marjani M
Curr Ther Res Clin Exp. 2021; 96:100658.
PMID: 34931090
PMC: 8673731.
DOI: 10.1016/j.curtheres.2021.100658.
Real-World Use of Fostamatinib in Patients with Immune Thrombocytopenia and Thrombotic Risk.
Mehta A, Kefela A, Toste C, Sweet D
Acta Haematol. 2021; 145(2):221-228.
PMID: 34913873
PMC: 9116595.
DOI: 10.1159/000520438.
Identification of transcriptional regulatory network associated with response of host epithelial cells to SARS-CoV-2.
Su C, Rousseau S, Emad A
Sci Rep. 2021; 11(1):23928.
PMID: 34907210
PMC: 8671548.
DOI: 10.1038/s41598-021-03309-5.
Bruton's TK regulates myeloid cell recruitment during acute inflammation.
Purvis G, Aranda-Tavio H, Channon K, Greaves D
Br J Pharmacol. 2021; 179(11):2754-2770.
PMID: 34897650
PMC: 9361009.
DOI: 10.1111/bph.15778.
Effects of the Btk-Inhibitors Remibrutinib (LOU064) and Rilzabrutinib (PRN1008) With Varying Btk Selectivity Over Tec on Platelet Aggregation and Bleeding Time.
Duan R, Goldmann L, Brandl R, Spannagl M, Weber C, Siess W
Front Cardiovasc Med. 2021; 8:749022.
PMID: 34631841
PMC: 8498029.
DOI: 10.3389/fcvm.2021.749022.
Platelet GPVI (Glycoprotein VI) and Thrombotic Complications in the Venous System.
Perrella G, Nagy M, Watson S, Heemskerk J
Arterioscler Thromb Vasc Biol. 2021; 41(11):2681-2692.
PMID: 34496636
PMC: 9653110.
DOI: 10.1161/ATVBAHA.121.316108.
Bruton tyrosine kinase inhibitors as potential therapeutic agents for COVID-19: A review.
Kifle Z
Metabol Open. 2021; 11:100116.
PMID: 34345815
PMC: 8318668.
DOI: 10.1016/j.metop.2021.100116.
Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets.
Bye A, Hoepel W, Mitchell J, Jegouic S, Loureiro S, Sage T
Blood. 2021; 138(16):1481-1489.
PMID: 34315173
PMC: 8321687.
DOI: 10.1182/blood.2021011871.
Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2.
Tammam S, El Safy S, Ramadan S, Arjune S, Krakor E, Mathur S
J Control Release. 2021; 337:258-284.
PMID: 34293319
PMC: 8289726.
DOI: 10.1016/j.jconrel.2021.07.028.
Reining in BTK: Interdomain Interactions and Their Importance in the Regulatory Control of BTK.
Kueffer L, Joseph R, Andreotti A
Front Cell Dev Biol. 2021; 9:655489.
PMID: 34249912
PMC: 8260988.
DOI: 10.3389/fcell.2021.655489.
